183 related articles for article (PubMed ID: 20146724)
1. Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa.
Peltzer K; Mlambo M; Phaswana-Mafuya N; Ladzani R
Acta Paediatr; 2010 May; 99(5):699-704. PubMed ID: 20146724
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa.
Peltzer K; Sikwane E; Majaja M
Acta Paediatr; 2011 Sep; 100(9):1253-7. PubMed ID: 21366691
[TBL] [Abstract][Full Text] [Related]
3. Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study.
Kuonza LR; Tshuma CD; Shambira GN; Tshimanga M
BMC Public Health; 2010 Apr; 10():218. PubMed ID: 20426830
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Prevention of mother-to-child transmission of HIV infection: views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi.
O'Gorman DA; Nyirenda LJ; Theobald SJ
BMC Public Health; 2010 Jun; 10():354. PubMed ID: 20565930
[TBL] [Abstract][Full Text] [Related]
6. Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.
Delvaux T; Elul B; Ndagije F; Munyana E; Roberfroid D; Asiimwe A
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):223-30. PubMed ID: 19131884
[TBL] [Abstract][Full Text] [Related]
7. A cluster randomized controlled trial of lay health worker support for prevention of mother to child transmission of HIV (PMTCT) in South Africa.
Peltzer K; Weiss SM; Soni M; Lee TK; Rodriguez VJ; Cook R; Alcaide ML; Setswe G; Jones DL
AIDS Res Ther; 2017 Dec; 14(1):61. PubMed ID: 29248014
[TBL] [Abstract][Full Text] [Related]
8. Self-reported adherence to single dose nevirapine in the prevention of mother to child transmission of HIV at Kitale District Hospital.
Bii SC; Otieno-Nyunya B; Siika A; Rotich JK
East Afr Med J; 2007 Dec; 84(12):571-6. PubMed ID: 18402309
[TBL] [Abstract][Full Text] [Related]
9. Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.
Napyo A; Tylleskär T; Mukunya D; Tumuhamye J; Musaba MW; Ojok Arach AA; Waako P; Tumwine JK; Ndeezi G
PLoS One; 2020; 15(10):e0240529. PubMed ID: 33057393
[TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa.
Mazanderani AH; Murray TY; Sherman GG; Snyman T; George J; Avenant T; Goga AE; Pepper MS; du Plessis N
J Int AIDS Soc; 2019 Jun; 22(6):e25284. PubMed ID: 31215757
[TBL] [Abstract][Full Text] [Related]
11. Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV.
Colvin M; Chopra M; Doherty T; Jackson D; Levin J; Willumsen J; Goga A; Moodley P;
Bull World Health Organ; 2007 Jun; 85(6):466-73. PubMed ID: 17639244
[TBL] [Abstract][Full Text] [Related]
12. Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting.
Barigye H; Levin J; Maher D; Tindiwegi G; Atuhumuza E; Nakibinge S; Grosskurth H
Trop Med Int Health; 2010 Oct; 15(10):1163-71. PubMed ID: 20667051
[TBL] [Abstract][Full Text] [Related]
13. Influence of the home environment on the prevention of mother to child transmission of human immunodeficiency virus/acquired immune-deficiency syndrome in South Africa.
Sewnunan A; Modiba LM
SAHARA J; 2015; 12():59-65. PubMed ID: 26694631
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E
Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822
[TBL] [Abstract][Full Text] [Related]
16. Factors determining HIV viral testing of infants in the context of mother-to-child transmission.
Peltzer K; Mlambo G
Acta Paediatr; 2010 Apr; 99(4):590-6. PubMed ID: 20064134
[TBL] [Abstract][Full Text] [Related]
17. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian Analysis of Prenatal Maternal Factors Predicting Nonadherence to Infant HIV Medication in South Africa.
Cook RR; Peltzer K; Weiss SM; Rodriguez VJ; Jones DL
AIDS Behav; 2018 Sep; 22(9):2947-2955. PubMed ID: 29302843
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
